Original language | English |
---|---|
Pages (from-to) | 381-382 |
Number of pages | 2 |
Journal | Pharmacoeconomics (Print) |
Volume | 36 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2018 |
Response to 'Comment on ''Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy"'
Amir Ansaripour, Carin Uyl - de Groot, Ken Redekop
Research output: Contribution to journal › Article › Academic › peer-review
6
Downloads
(Pure)